Psychiatric researchers are challenging claims that the ketogenic diet can 'cure' schizophrenia, though they acknowledge its promise for various mental health conditions. The statements, attributed to Harvard psychiatrist Dr. Christopher Palmer, suggest the diet can induce remission of symptoms, not provide a cure. Palmer himself clarified he has not used the word 'cure' but sees the ketogenic diet as a powerful treatment.
The ketogenic diet, characterized by high fat and low carbohydrate intake, differs significantly from the "carnivore diet" followed by Robert F. Kennedy Jr. Evidence for keto's impact on schizophrenia stems from two case reports published by Palmer, which described symptom improvement in patients using the diet for other health reasons.
Palmer emphasized these case reports are preliminary and not conclusive proof, but valuable for generating treatment hypotheses. He stressed that patients should never stop psychiatric medications without strict medical supervision, citing a case where sudden discontinuation led to severe psychosis and hospitalization.
The ketogenic diet has a history as a treatment for epilepsy since the 1920s and is seeing renewed interest from psychiatric researchers. Around 20 controlled trials are currently underway to investigate its efficacy for conditions like schizophrenia and bipolar disorder. Potential benefits may extend to managing medication side effects.
Scientists are exploring the diet's mechanism, with theories pointing to its effects on mitochondria, the "powerhouses" of cells, which are implicated in many psychiatric disorders. Research also suggests keto may alter brain glutamate levels, correlating with symptomatic improvement in some cases.
However, questions remain about the long-term viability and cost-effectiveness of the ketogenic diet for patients, as it requires significant dietary adherence and can be expensive. Further research is needed to determine if modified versions can be sustainable.